Learn More
Medchemexpress LLC 8-[5-(difluoromethyl)pyridin-3-yl]-1-(2,3,6,7-tetrahydrooxepin-4-yl)triazolo[4,3-a]quinoxaline | 2763602-59-9 | 99.4% | C21H17F2N5O | 10MG

Supplier: Medchemexpress LLC HY13229310MG
BAY-8400 is an orally active, potent, and selective DNA-dependent protein kinase (DNA-PK) inhibitor (IC50 = 81 nM) used in oncology research. It has shown antiproliferative effects in multiple cancer cell lines and oral bioavailability in vivo; supplier data report high purity, defined storage conditions, and good solubility in DMSO, making it suitable for in vitro and in vivo research applications.
- Potent DNA-PK inhibition (IC50 81 nM).
- Orally active with reported in vivo bioavailability.
- Antiproliferative activity in multiple cancer cell lines.
- High reported purity for research use.
- Good DMSO solubility for in vitro assays.
- Stable when stored under recommended conditions.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.